Viewing nowAtorren Tablets 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.

MFDS item code 201506583 · Approved 2015.09.16 · Insurance code 660702900
Improvement of hyperlipidemia (including familial hypercholesterolemia in children) and prevention of cardiovascular events (e.g., myocardial infarction)
This medication helps reduce the risk of cardiovascular disease. It particularly decreases the risk of myocardial infarction and stroke in the elderly, smokers, those with hypertension, and those with a family history. It also aids in reducing the risk of cardiovascular disease in diabetic patients. For patients who already have heart disease, it reduces the risk of hospitalization due to myocardial infarction, stroke, angina, and congestive heart failure. Additionally, when used alongside dietary therapy for hyperlipidemia, it is useful in lowering total cholesterol, LDL cholesterol, and triglyceride levels, and in raising HDL cholesterol levels to help maintain healthy blood lipid levels. For pediatric patients aged 10 to 17 years with familial hypercholesterolemia, it is used as an adjunct to diet to effectively control blood cholesterol levels. Overall, this medication is used to improve cardiovascular disease and hyperlipidemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20mg or 40mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ∼ 80mg once daily. The initial and maintenance doses should be individualized according to patient characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ∼ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels may be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ∼ 80mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not possible. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
2. Pediatric patients (10 ∼ 17 years) with heterozygous familial hypercholesterolemia The recommended initial dose is 10mg of this medicine once daily, and the recommended maximum dose is 20mg daily (there are no clinical data on administration of doses higher than 20mg of this medicine in pediatric patients.). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may pose a risk of muscle problems; if symptoms like muscle pain or weakness occur, discontinue use immediately and consult a physician. This medication should not be used by patients with certain diseases, such as those with liver or muscle disorders, pregnant women or those who may become pregnant, children under 10 years of age, or patients taking certain other medications. Patients with liver or kidney issues or alcohol dependence should be especially cautious while taking this medication, and regular check-ups should be performed to monitor their condition. While this medication is generally safe, rare side effects such as liver function abnormalities, allergic reactions, dyspepsia, headaches, muscle pain, and skin rashes may occur; immediate notification to a physician is required if any abnormal symptoms arise. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use appropriate contraception while taking this medication. This medication may interact with various other medications; thus, inform the doctor or pharmacist if other medications are being taken, especially if taking specific antibiotics, antiviral agents, antifungals, blood pressure medications, or oral contraceptives. There is no specific antidote for overdose, so treatment should be symptomatic, and careful monitoring of liver function and muscle status should be conducted. This medication should be kept out of the reach of children and should not be stored in a different container from its original packaging. Elderly patients are at a higher risk of muscle-related side effects, so they require close monitoring while taking this medication. Furthermore, if symptoms such as muscle pain, muscle weakness, fatigue, or fever occur during treatment, medical assistance should be sought immediately, and if symptoms are severe or CK levels are elevated, the medication should be discontinued.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1°C and 30°C at room temperature.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.